科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 5,790 | 5,790 | 5,730 | 5,750 | -20 | -0.3% | 52,700 |
2018/07/17 | 5,600 | 5,810 | 5,600 | 5,770 | +190 | +3.4% | 141,300 |
2018/07/13 | 5,540 | 5,600 | 5,510 | 5,580 | +40 | +0.7% | 71,400 |
2018/07/12 | 5,500 | 5,610 | 5,500 | 5,540 | +40 | +0.7% | 108,300 |
2018/07/11 | 5,630 | 5,670 | 5,500 | 5,500 | -180 | -3.2% | 198,100 |
2018/07/10 | 5,720 | 5,770 | 5,670 | 5,680 | ±0 | ±0% | 121,300 |
2018/07/09 | 5,700 | 5,720 | 5,650 | 5,680 | -10 | -0.2% | 78,000 |
2018/07/06 | 5,610 | 5,780 | 5,530 | 5,690 | -80 | -1.4% | 302,900 |
2018/07/05 | 5,770 | 5,810 | 5,750 | 5,770 | +30 | +0.5% | 146,200 |
2018/07/04 | 5,650 | 5,760 | 5,640 | 5,740 | +40 | +0.7% | 103,700 |
2018/07/03 | 5,660 | 5,720 | 5,650 | 5,700 | +50 | +0.9% | 81,600 |
2018/07/02 | 5,690 | 5,760 | 5,640 | 5,650 | -40 | -0.7% | 115,900 |
2018/06/29 | 5,700 | 5,750 | 5,680 | 5,690 | -30 | -0.5% | 139,000 |
2018/06/28 | 5,850 | 5,860 | 5,710 | 5,720 | -210 | -3.5% | 137,500 |
2018/06/27 | 5,870 | 5,970 | 5,870 | 5,930 | +80 | +1.4% | 99,900 |
2018/06/26 | 5,840 | 5,880 | 5,780 | 5,850 | +40 | +0.7% | 83,000 |
2018/06/25 | 5,890 | 5,900 | 5,760 | 5,810 | -80 | -1.4% | 91,900 |
2018/06/22 | 5,810 | 5,920 | 5,810 | 5,890 | +80 | +1.4% | 110,200 |
2018/06/21 | 5,840 | 5,910 | 5,800 | 5,810 | -70 | -1.2% | 163,800 |
2018/06/20 | 5,870 | 5,920 | 5,800 | 5,880 | +50 | +0.9% | 142,100 |
2018/06/19 | 5,840 | 5,870 | 5,780 | 5,830 | -20 | -0.3% | 116,100 |
2018/06/18 | 5,850 | 5,920 | 5,820 | 5,850 | ±0 | ±0% | 112,500 |
2018/06/15 | 5,860 | 5,940 | 5,850 | 5,850 | +30 | +0.5% | 136,900 |
2018/06/14 | 5,820 | 5,880 | 5,780 | 5,820 | ±0 | ±0% | 95,600 |
2018/06/13 | 5,810 | 5,910 | 5,810 | 5,820 | +10 | +0.2% | 100,800 |
2018/06/12 | 5,740 | 5,810 | 5,720 | 5,810 | +40 | +0.7% | 93,900 |
2018/06/11 | 5,780 | 5,810 | 5,710 | 5,770 | -10 | -0.2% | 78,300 |
2018/06/08 | 5,790 | 5,830 | 5,750 | 5,780 | +30 | +0.5% | 136,400 |
2018/06/07 | 5,730 | 5,750 | 5,690 | 5,750 | +20 | +0.3% | 103,800 |
2018/06/06 | 5,710 | 5,780 | 5,710 | 5,730 | -20 | -0.3% | 103,800 |
2018/06/05 | 5,730 | 5,760 | 5,660 | 5,750 | ±0 | ±0% | 190,800 |
2018/06/04 | 5,970 | 6,050 | 5,720 | 5,750 | -320 | -5.3% | 313,300 |
2018/06/01 | 6,020 | 6,120 | 5,990 | 6,070 | +40 | +0.7% | 79,900 |
2018/05/31 | 5,980 | 6,060 | 5,970 | 6,030 | +20 | +0.3% | 112,100 |
2018/05/30 | 6,000 | 6,050 | 5,990 | 6,010 | -40 | -0.7% | 97,000 |
2018/05/29 | 6,030 | 6,100 | 6,010 | 6,050 | +20 | +0.3% | 64,100 |
2018/05/28 | 6,100 | 6,110 | 6,010 | 6,030 | -70 | -1.1% | 87,600 |
2018/05/25 | 6,150 | 6,200 | 6,090 | 6,100 | -120 | -1.9% | 147,100 |
2018/05/24 | 6,200 | 6,280 | 6,190 | 6,220 | +20 | +0.3% | 111,700 |
2018/05/23 | 6,130 | 6,220 | 6,130 | 6,200 | +20 | +0.3% | 93,000 |
2018/05/22 | 6,130 | 6,190 | 6,110 | 6,180 | +50 | +0.8% | 67,100 |
2018/05/21 | 6,160 | 6,170 | 6,120 | 6,130 | -30 | -0.5% | 70,300 |
2018/05/18 | 6,090 | 6,170 | 6,020 | 6,160 | +10 | +0.2% | 164,800 |
2018/05/17 | 6,270 | 6,310 | 6,090 | 6,150 | -50 | -0.8% | 169,700 |
2018/05/16 | 6,300 | 6,400 | 6,110 | 6,200 | -180 | -2.8% | 231,100 |
2018/05/15 | 6,300 | 6,450 | 6,290 | 6,380 | +150 | +2.4% | 105,000 |
2018/05/14 | 6,270 | 6,320 | 6,170 | 6,230 | -40 | -0.6% | 140,700 |
2018/05/11 | 6,180 | 6,310 | 6,180 | 6,270 | +110 | +1.8% | 131,500 |
2018/05/10 | 6,270 | 6,410 | 6,080 | 6,160 | -90 | -1.4% | 194,700 |
2018/05/09 | 6,500 | 6,600 | 6,080 | 6,250 | -170 | -2.6% | 335,200 |
1651~
1700
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム